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ABSTRACT 
Caused by a yeast-like organism known as Lacazia loboi, Lobomycosis (or lacaziosis) naturally affects 
humans, common bottlenose dolphins (Tursiops truncatus) inhabiting coastal waters from southern Brazil 
to Gulf of Mexico and Atlantic coast of Florida, as well as botos-cinza (Sotalia guianensis). These species 
are usually found in coastal waters, subject to runoff provided by large rivers and a considerable burden 
of associated contaminants. Histological and morphological studies demonstrated that the etiological 
agent of  L. Loboi infecting humans is different from the one found to infected dolphins. Moreover, it 
likely that dolphin-human infections do not occur although infected bottlenose dolphins were from 
populations engaged in cooperative fishing that involve a relative small number of dolphins and humans. 
The records of Lobomycosis and Lobomycosis-like disease (LLD) in Tramandaí estuary (29o58´S), Rio 
Grande do Sul, Brazil, represent the southernmost distribution of L. loboi. On the other hand, the 
northernmost distribution of this disease is reported in the southern portion of Indian River Lagoon 
(27o25´N), Florida, USA. LLD seems to be more widespread, infecting both toothed small cetaceans and 
baleen whales, from the tropical Atlantic to the Pacific. Future studies should evaluate the association 
with impaired immune function in affected dolphins and the emergency of Lobomycosis. It may be 
associated with an immunosuppressive factor of environmental origin, such as exposure to pesticides or 
other agricultural or industrial contaminants, introduced through runoff or point sources of pollution, 
altering conditions to favour disease emergence. Lobomycosis should be assigned as neglected tropical 
disease, as should be the case of LLD, if future investigations indicate their connection as an emerging 
pathogen, its pathogenicity and environment requirements. 
INTRODUCTION 
Caused by a yeast-like organism known as Lacazia loboi (Taborda et al., 1999) (syn. Loboa loboi; 
Caldwell et al., 1975), Lobomycosis (or lacaziosis) naturally affects humans, common bottlenose 
dolphins (Tursiops truncatus) and botos-cinza (Sotalia guianensis) (de Vries and Laarman, 1973; 
Caldwell et al., 1975; Simões-Lopes et al., 1993; Reif et al., 2006; Van Bressem et al., 2007). L. loboi 
infecting T. truncatus from North and South America may be different from the one found in humans 
(Haubold et al., 2000). Until recently it was believed that the same species (fungus) was the etiologic 
agent for the Lobomycosis in humans and dolphins but a morphological study showed significant 
differences in size and potential differences in host/organism interaction between the two agents (Haubold 
et al. 2000).  The authors point some factors that could influence in the divergence of the two 
Lobomycosis “forms” (e.g. different environments occupation between the dolphins and humans and 
different core body temperature). In other hand, a recently study suggest that humans are infected with 
similar L. loboi strains to those infecting dolphins (Mendoza et al. 2008), showing that this issue remain 
to be satisfactory described and interpreted. Instead some evidences of contamination exist in the 
literature (Symmers 1983) there is some controversy (Norton 2006). The possible existence of two 
different organisms as well the distribution characteristic of the Lobomycosis in human and dolphins 
could explain the low or inexistent risk of contamination between humans and dolphins.  In humans, 
Lobomycosis is a self-limited, chronic fungal infection of the skin endemic in rural regions in South and 
Central America. The natural reservoir of L. loboi is unknown but soil and vegetation seem to be likely 
sources of infection for humans (Honda et al., 2007). Patients with Lobomycosis may have 
immunoregulatory disturbances possibly responsible for the lack of pathogen containment (Vilani-
Moreno et al., 2005; Honda et al., 2007). Lobomycosis in dolphins is characterized by whitish to slightly 
pink, verrucous lesions, often in pronounced relief that may ulcerate (Migaki et al., 1971). In T. truncatus 
from the southern part of the Indian Lagoon, Florida, the disease was associated with an impaired 
immune function possibly caused by anthropogenic factors. Variation in salinity and water temperature 
may also play a role (Reif et al., 2006). The apparent emergence of Lobomycosis and Lobomycosis-like 
disease (LLD) in coastal T. truncatus from Colombia, Ecuador, Peru and Brazil was recently reported 
(Van Bressem et al., 2007). At least two T. truncatus from Brazil have died with extensive Lobomycosis 
(Simões-Lopes et al., 1993; Van Bressem et al., 2007). Lobomycosis needs to be recognized as a public 
health problem in coastal South America and other similar endemic areas. We propose the recognition of 
Lobomycosis as a neglected tropical disease such as leishmaniasis (kala-azar), onchocerciasis (river 
blindness), Chagas disease, leprosy, tuberculosis, schistosomiasis (bilharzias), lymphatic filariasis, 
African trypanosomiasis (sleeping sickness), and dengue. 
 
MATERIAL AND METHODS 
We reviewed the available information on Lobomycosis published in scientific journals since its original 
description by Brazilian dermatologist Jorge de Oliveira Lôbo in 1931 (Lacaz et al. 1986). At least 12 
articles on peer-reviewed publications have diagnosed Lobomycosis in bottlenose dolphins ranging from 
Florida to Texas, in the United States, south to Santa Catarina, in southern Brazil. More recently there is 
one confirmed new case for Rio Grande do Sul, south Brazil (see Moreno et al. 2008, this workshop). The 
emergency of an apparently similar to Lobomycosis mycotic disease, evidencing probable unconfirmed 
cases of such pathology in cetaceans from South America, so far called Lobomycosis-like disease (LLD) 
(Van Bressem et al. 2007), has been pointed out in the literature. Since then, several new cases of  LLD 
have been indicated in cetaceans, mostly Odontoceti (T. truncatus and S. guianensis) but also Mysticeti 
(Balaenoptera brydei), in the Atlantic and Pacific Oceans. 
RESULTS AND DISCUSSION 
Geographic distribution of Lobomycosis and LLD 
In dolphins, Lobomycosis is widely distributed occurring from southern Brazil (Tramandaí River) to Gulf 
of Mexico and Atlantic coast of Florida (Reif et al. 2006, Van Bressem et al. 2007). In South western 
Atlantic Ocean the Lobomycosis was first reported from a bottlenose dolphin beached in 1990 in Laguna 
(28o30’S, 48o45’W), Santa Catarina State, in southern Brazil (Simões-lopes et al. 1993). This was the 
only known case until recently where the apparent re-emergence of Lobomycosis and Lobomycosis-like 
disease (LLD) in coastal dolphins from Brazil, Colombia, Ecuador and Peru was reported (Bermúdez-
Villapol et al. 2008, Van Bressem et al. 2007). At least eight new cases of undetermined mycotic 
diseases, including LLD, in T. truncatus from coastal populations in southern Brazil, were reported 
(Moreno et al. 2008, this paper). Figure 1 shows reported cases of Lobomycosis and LLD in cetaceans 
from South and North America. 
 
Pathogenesis 
 
The pathogenesis of Lobomycosis is unknown. This is caused primarily because the fungus cannot be 
cultured in the laboratory. L. loboi lives in the soil, water and vegetables, in a saprophytic way, acting as a 
pathogenic agent when it is able to infect vertebrates, as humans and dolphins. The agent is able to 
penetrate through the skin, depending of the cutaneous traumatism. It has been referred that previous 
small wounds in humans has preceded the mycotic lesions (Lacaz et al. 1986). However, in stranded 
dolphins, Lobomycosis has been associated with immunologic compromise and mutisystemic disease 
(Bossart, 1984). 
 Etiological aspects of Lobomycosis in dolphins 
Lacaz et al. (1986) have called the attention that Lobomycosis is spontaneously found in dolphins as 
ulcerated crusts lesions in the skin, usually located in the flukes or the back of the animals. Those authors 
also provided a first collection of reported cases in dolphins. Until recently it was believed that the same 
species (fungus) was the etiologic agent for the Lobomycosis in humans and dolphins but a 
morphological study showed significant differences in size and potential differences in host/organism 
interaction between the two agents (Haubold et al. 2000). The authors point some factors that could 
influence in the divergence of the two Lobomycosis “forms” (e.g. different environments occupation 
between the dolphins and humans and different core body temperature). In other hand, a recently study 
suggest that humans are infected with similar L. loboi strains to those infecting dolphins (Mendoza et al. 
2008), showing that this issue remain to be satisfactory described and interpreted. Instead some evidences 
of contamination exist in the literature (Symmers 1983) there is some controversy (Norton 2006). The 
possible existence of two different organisms as well the distribution characteristic of the Lobomycosis in 
human and dolphins could explain the low or inexistent risk of contamination between humans and 
dolphins.  In humans, Lobomycosis is a self-limited, chronic fungal infection of the skin endemic in rural 
regions in South and Central America. 
In fact, the distribution of dolphins’ cases of Lobomycosis and LLD and in humans seems to be 
parapatric. More intriguing is the apparent lack of reported cases of Lobomycosis and LLD for freshwater 
mammals, like the Amazonian manatee (Trichechus inunguis), tucuxis (Sotalia fluviatilis) and botos (Inia 
geoffrensis). It should be noted that Da Silva et al. (2008, this workshop) have not indicated the presence 
of Lobomycosis or LLD in 385 botos examined in central Amazonia from 1994 to 2007. In addition, no 
evidence of such mycotic pathologies was found in coastal populations of S. guianensis studied in coastal 
Pará state waters since 2004 (N.R. Emin-Lima and S. Siciliano, pers. observ.), as well as over 90 botos-
cinza incidentally captured off Amapá, or in I. geoffrensis observed in the vicinities of Belém, Para’s 
capital and coastal Marajó Isl., northern Brazil. It should be emphasized that other pathologies were 
noticed in S. guianensis from the Marajó bay area and off Amapá, as reported in this workshop. 
Epidemiology of Lobomycosis 
In humans, Lobomycosis is most common in farmers, rubber workers, hunters, and prospectors, but some 
travellers are also affected. The natural reservoir of the fungus is unknown but soil and vegetation seem to 
be likely sources of infection for humans (Honda et al. 2007). All human cases in Brazil are distributed 
almost exclusively in the tropical zone in North and North-eastern regions were the high temperature 
(mean 24oC) and humidity favours the occurrence of mycosis (Brito and Quaresma 2007). Conversely, in 
dolphins all cases are concentrated in Southern region in the estuarine/marine environment under the 
influence of the Subtropical Convergence (Simões-lopes et al. 1993; Van Bressem et al. in press) showing 
a likely parapatric distribution. The same pattern occurs in Venezuela were all human cases are described 
in inland zones generally at 200-250m over the sea level heights with high temperature, precipitation and 
humidity (Paniz-Mondolfi et al. 2007) and the recent case described in literature is present in marine 
environment (Bermúdez-Villapol et al. 2008, this workshop).   
In dolphins, especially T. truncatus, Lobomycosis is likely to be lethal in older dolphins, subject to severe 
ulcerative and crosstie lesions, widespread over the flanks, ventral body, jaws, flippers and tailstock 
(Simões-Lopes et al. 1993, Moreno et al. 2008). Both sexes seem to be equally affected. Lobomycosis 
seems to be epidemic in small coastal populations of dolphins, with highly social structure and affective 
bonds. This could explain the prevalence of such pathology in several small dolphin populations confined 
to coastal habitats along North and South America. 
The epidemic re-emergency of Lobomycosis and LLD along southern and south-eastern Brazil 
As pointed out by Van Bressem et al. (2007), naïve populations are more susceptible to develop 
Lobomycosis and LLD, as might be the case of the T. truncatus of Baía Norte and S. guianensis of 
Guaraqueçaba. In T. truncatus from the southern part of the Indian Lagoon, Florida, the disease was 
associated with an impaired immune function possibly caused by anthropogenic factors. Variation in 
salinity and water temperature may also play a role (Reif et al., 2006). Alternatively, the marked gradient 
in the distribution of Lobomycosis from the southern to the northern portion of the Indian River Lagoon 
may reflect variations in water temperature, salinity, or vegetation and enhanced survival of the organism 
in the marine environment (Reif et al 2006). Probably the lower water temperatures in southern Rio 
Grande do Sul State during winter (around 10oC) may constrain the survival of L. loboi. 
As Lobomycosis and LLD diseases have only been recently reported in bottlenose dolphins from Baía 
Norte, Santa Catarina state, and botos-cinza in Guaraqueçaba, Paraná state, Brazil (Flach et al. 2008, this 
workshop, Van Bressem et al. 2008, this workshop), it seems to be the re-emergency of the etiologic 
agent of Lobomycosis among coastal Brazilian dolphins. Moller et al. (1994) have shown that T. 
truncatus photo-identified in Tramandaí were resighted in Mampituba and Laguna, over 200km north of 
its original site. It is though possible that transient T. truncatus and S. guianensis are getting contact with 
infected populations from different sites along southern Brazil, providing the opportunity to infect naïve 
populations. Evidence of LLD in baleen whales also requires more in-depth investigation for confirming 
the agent involved in such pathologies.  
Lobomycosis like-disease (LLD), a newly reported disease in dolphins and whales from South America? 
Van Bressem et al. (2007) reported a variety of cases of dolphins with possible Lobomycosis-like 
diseases (LLD) in different areas of South America. New evidence is provided for southern Brazil, Gulf 
of Guayaquil (Ecuador), Bahia Malaga and surroundings (Colombia), Callao (Peru) and Isla Margarita 
(Venezuela). It is thus indicated a widespreading of LLD from the tropical-subtropical Atlantic to the 
Pacific coast. It seems that LLD, as a disease previously known only to the Atlantic coast may be present 
in the Pacific coast or represents a new mycotic disease in dolphins and whales yet to be described. 
More intriguing is the fact that Sotalia guianensis from the Cananéia estuary, in southern São Paulo state 
coast, does not show any evidence of LLD. Conversely, the S. guianensis population in Guaraqueçaba, 
adjacent to Cananéia, has presented a large proportion of dolphins with skin disorders, most likely LLD 
(Van Bressem et al, 2008). 
Lobomycosis as a neglected tropical disease 
International attention is currently mainly focused on the “big three” of HIV/AIDS, malaria and 
tuberculosis, but attention to other infectious diseases, which have a very strong negative impact on poor 
human populations, is neglected. Neglected diseases are neither perceived as priorities by the health 
systems of developing countries nor by sponsoring international agencies and philanthropic organizations 
and they escape especially the attention of the pharmaceutical industry. Therefore they require special 
attention when the research agendas are set and development of new tools discussed.  So far, there is no 
generally accepted definition of neglected diseases (WHO, 2007). There are several attempts which look 
at the problem from different angles. A valid approach from the research point of view is to define 
neglected diseases as those for which there is an insufficient market or political status to drive adequate 
private sector and public sector research and development (R&D). Depending on the source a quite large 
number of diseases may fall into this category, like human African trypanosomiasis, buruli ulcer, Chagas 
disease, dengue fever, filariasis, guinea worm, leishmaniasis, leprosy, malaria, onchocerciasis, rabies, 
schistosomiasis and tuberculosis.  
According to WHO definitions, Lobomycosis should be assigned as a tropical neglected disease affecting 
both humans and dolphins. Further investigation should provide light into the epidemiology of 
Lobomycosis-like disease, whether it represents a mycotic agent yet to be described or a widespread 
“form” of Lobomycosis. The role of environmental factors should also be addressed, as coastal 
environments are changing dramatically in the last decades. 
CONCLUSIONS 
In cetaceans, Lobomycosis is reported in only two dolphin species (T. truncatus and S. guianensis) 
inhabiting coastal waters from southern Brazil (Tramandaí River) to Gulf of Mexico and Atlantic coast of 
Florida. These species are usually found in coastal waters, subject to runoff provided by large rivers and a 
considerable burden of associated contaminants. 
Histological and morphological studies demonstrated that the etiological agent of L. Loboi infecting 
humans is different from the one found to infected dolphins. Moreover, it likely that dolphin-human 
infections do not occur although infected dolphins were from populations engaged in cooperative fishing 
that involve a relative small number of dolphins and humans. 
The records of Lobomycosis in Tramandaí estuary (29o58´S) represent the southernmost distribution of L. 
loboi. On the other hand, the northernmost distribution of this disease is reported in the southern portion 
of Indian River Lagoon (27o25´N), Florida, USA. LLD seems to be more widely diffused, infecting both 
toothed small cetaceans and baleen whales, from the tropical Atlantic to the Pacific. 
 
Future studies should evaluate the association with impaired immune function in affected dolphins and 
the emergency of Lobomycosis. It may be associated with an immunosuppressive factor of environmental 
origin, such as exposure to pesticides or other agricultural or industrial contaminants, introduced through 
runoff or point sources of pollution, altering conditions to favour disease emergence. Lobomycosis should 
be assigned as neglected tropical disease, as should be the case of LLD, if future investigations indicate 
their connection as an emerging pathogen, its pathogenicity and environment requirements. 
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Figure 1. Known distribution of reported cases of Lobomycosis and Lobomycosis-like disease (LLD) in 
cetaceans in the Americas. 
 
 
